首页 产品目录 全部产品 Guselkumab单抗

Guselkumab单抗

Guselkumab

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1350289-85-8

中文名称

Guselkumab单抗

英文名称

Guselkumab

别名

guselkumab;Research Grade Guselkumab(DHJ63103);Guselkumab (anti-IL-23);CNTO 1959;Research Grade Guselkumab

用途

Guselkumab is the first-in-class monoclonal antibody targeting IL-23 developed by Janssen. It was approved by the FDA in July 2017 for the treatment of adult patients with moderate to severe plaque psoriasis. On November 26, 2018, TREMFYA (guselkumab) was approved in Hong Kong for the treatment of adult patients with moderate to severe plaque psoriasis.

安全信息

评论 0
我是晶智Agent,
您的化学小助手